Clinical trial
A Randomized, Parallel-group Study of Terconazole Vaginal Suppository vs Fluconazole for the Treatment of Severe
NCT02180100 is registered in ClinicalTrials.gov with Peking University Shenzhen Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Parallel-group Study of Terconazole Vaginal Suppository vs Fluconazole for the Treatment of Severe
- Lead sponsor
- Peking University Shenzhen Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2013
- Completion date
- June 30, 2014
- Enrollment
- 140 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
vulvovaginal candidiasis